Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

IRBT Deadline: IRBT Investors with Losses in Excess of $100K Have Opportunity to Lead iRobot Corporation Securities Fraud Lawsuit

NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of iRobot Corporation (NASDAQ: IRBT) between January 29, 2024 and Ma...

What is the likely impact on institutional and retail investors' positions and trading volumes for IRBT? How might the lawsuit affect iRobot's future revenue forecasts and earnings guidance? Will the potential lawsuit settlement create upside pressure on IRBT's stock price?
Symbol: IRBT
Lawsuits
about 17 hours ago
Read more prnewswire

Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the U.S. Food and Drug Administration (FDA) has approved the...

How might this milestone influence market expectations for future regulatory decisions on variant‑adapted vaccines and pricing strategies? What immediate impact is expected on Pfizer's stock price relative to competitors like Moderna and Novavax? How will the FDA approval for expanded age groups affect Pfizer's vaccine sales forecasts and revenue outlook?
Symbol: PFE
Approval
about 17 hours ago
Read more businesswire

Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

NEW YORK and MAINZ, GERMANY, AUGUST 27, 2025 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the U.S. Food and Drug Administration (FDA) has approved ...

How might this approval influence Pfizer’s market share, pricing power, and stock volatility in the US COVID‑19 vaccine market? What competitive advantage does the LP.8.1‑adapted monovalent vaccine provide versus Moderna, Novavax, and other COVID‑19 boosters? How will the expanded FDA indication for COMIRNATY® LP.8.1 affect Pfizer’s revenue forecasts and guidance?
Symbol: PFE
Approval
about 17 hours ago
Read more globenewswire

Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.

BETHESDA, Md., Aug. 27, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for sol...

When is the merger expected to close and what are the regulatory or integration risks that could influence stock volatility? What are the terms of the deal and the expected dilution or financing impact on existing shareholders? How will the acquisition affect Northwest Biotherapeutics' financial performance and cash flow?
Symbol: NWBO
Mergers
about 18 hours ago
Read more prnewswire

Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.

BETHESDA, Md., Aug. 27, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for sol...

Will the deal result in dilution or additional financing that could impact the share price? What are the expected synergies and integration timeline for Advent BioServices? How will the acquisition affect NWBO's financial outlook and cash flow projections?
Symbol: NWBO
Mergers
about 18 hours ago
Read more prnewswire